Retour
Prix Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (02315.HK)
Graphique du cours de l'action 02315.HK
BIOCYTOGEN-B (02315.HK)
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
HK$39.56
-8.59%
$-3.71
Marché Régulier: Jan 19, 14:05:00 HKT
Statistiques clés
Clôture préc.
$43.28
Prix d'ouverture
$43.28
Plage de la journée
$39.42 - $43.28
Plage de 52 semaines
$7.07 - $39.56
Volume
1.4M
Volume moyen
689.4K
BPA (TTM)
0.37
Rendement en dividend
--
Capitalisation boursière
$4.2B
Qu’est-ce que BIOCYTOGEN-B ?
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. manufactures biological products and provides related biological services. The company is headquartered in Beijing, Beijing and currently employs 1,306 full-time employees. The company went IPO on 2022-09-01. The firm utilizes its self-developed RenMice fully human antibody and T-cell receptor (TCR) mouse platform for large-scale drug discovery and development targeting potential drug targets in the human body. The Company’s main businesses include the sale of innovative animal models, pre-clinical pharmacology and efficacy evaluation services, and antibody development. The firm is also engaged in the provision of gene-editing services. The firm operates its businesses in the domestic market and overseas markets.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved
